Blog For Free!
Archives
Home
2009 November
2009 October
2009 September
2009 August
2009 July
2009 June
2009 May
2009 April
2009 March
2009 February
2009 January
2008 December
2008 November
2008 October
2008 September
2008 August
2008 July
2008 June
2008 May
2008 April
2008 March
2008 February
2007 December
2007 November
2007 October
2007 September
2007 August
My Links
Ankitsmart
Surrogate
Ggirl
Raggedtiger
Antonio
Drforbush
Mcgowan
Jokebest
Thissideoftheuniverse
Enggdeepak
Christieheals
Fractalmom
Angelsdreams
inkspector
Emerging
Ken
Pirate Girl
LadyG
The Freshmaker
Pastor Dave
Bxgladiator
Grey71
mcgowan
tBlog
My Profile
Send tMail
My tFriends
My Images
Sponsored
Blog
| Supress Science and Ban the Natural...for Big Pharma |
| 06.24.09 (2:07 pm) [edit] |
Big Pharma and the FDA: Suppress the Science and Ban the Natural
In 2005, the pharmaceutical company Biostratum, Inc. made a mistake -- they invested millions of dollars into developing a drug, only to discover that the active ingredient, pyridoxamine, was a common, naturally occurring substance that has been sold for decades at low cost.
Biostratum responded by asking the U.S. FDA to declare supplements containing pyridoxamine “adulterated,” and effectively ban anyone but Biostratum from selling pyridoxamine. Earlier this year the FDA agreed to ban companies from selling pyridoxamine as a dietary supplement.
The FDA’s comment on the decision specifically says, “To allow such an article to be marketed as a dietary supplement would not be fair to the pharmaceutical company that brought, or intends to bring, the drug to market.”
Apparently, they were not as concerned about fairness to consumers.
This is hardly the first time the FDA has attacked naturally occurring substances. The FDA has banned information about scientifically proven health benefits of cherries from appearing on Web sites. And for years, the FDA barred health claims about the benefits of omega-3 fats for heart, cancer, depression, body pain, and various other conditions until a drug company paid a great deal of money to go through the approval process.
In the case of pyridoxamine, the FDA did not act out of concern for public safety. This is about a profit-seeking corporation taking advantage of corruption in what is supposed to be a public health organization
|